Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2026-02-27 @ 6:12 PM
Study NCT ID:
NCT05088460
Status:
TERMINATED
Last Update Posted:
2025-10-16
First Post:
2021-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)
Sponsor:
Regeneron Pharmaceuticals
Organization: